Vallon Pharmaceuticals Inc (VLON)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -1.4M | -1.39M | -2.35M | -4.57M | -2.44M | -2.03M | -1.9M | -2.26M |
税引前収入 | -1.03M | -1.58M | -2.4M | -6.5M | -2.14M | -2M | -1.89M | -2.25M |
純利益 | -1.03M | -1.58M | -2.4M | -6.5M | -2.14M | -2M | -1.89M | -2.25M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.4M | -1.39M | -2.35M | -4.57M | -2.19M | -2.03M | -1.9M | -2.26M |
EBITDA | -1.4M | -1.39M | -2.35M | -4.57M | -2.44M | -2.03M | -1.89M | -2.26M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 100k | 0 | 0 | 0 |
営業利益 | -4.31M | -3.15M | -4.79M | -9.26M | -6.93M | -11.39M |
税引前収入 | -4.31M | -3.46M | -4.82M | -9.3M | -7.02M | -13.04M |
純利益 | -4.31M | -3.46M | -4.82M | -9.3M | -7.02M | -13.04M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
EBIT | -4.31M | -3.15M | -4.79M | -9.2M | -6.93M | -11.14M |
EBITDA | -4.31M | -3.15M | -4.79M | -9.26M | -6.93M | -11.38M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約